Consistent with this finding, in the current study, we observed that the protein expression levels of CPT1 and ABCA1 were reduced in the FFA-stimulated NAFLD cellular model. This evidence concerns the gene ABCA1 and metabolic dysfunction-associated steatotic liver disease.